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ABSTRACT
Background and Purpose: Multiple sclerosis (MS) is a disease determined by the interaction 
of genetic and environmental factors. Metals are suspected of being involved in MS. There is 
not any epidemiologic study about mines and MS. The purpose of this study was to determine 
MS prevalence according to mines in Kerman province.
Methods: This cross-sectional study was conducted on 932 patients in Kerman province in 
2012. The details of the patients including age, sex, age at the onset of disorder and disease 
duration were collected from documents of MS centres of Kerman and Rafsanjan Universities 
of Medical Science. Diagnosis was confirmed according to the revised Mc-Donald criteria. To 
analyze the data, SPSS-17 software and descriptive statistics and t-test were used
Results: The male/ female ratio was 1:3. The prevalence of MS in Kerman province was 
31.7 per 100000. Kerman, Sirjan, Zarand and Rafsanjan had the highest prevalence of MS, 
respectively. The mean prevalence of MS in mineral areas in Kerman province (Kahnoj, Sirjan, 
Zarand, Rafsanjan, Baft, Shahrbabak) was 23.01±10.78 and in non-mineral areas (Kerman, 
Bam, Jiroft) was 39.56±20.34 that show the higher prevalence of MS in non-mineral areas of 
Kerman province.
Conclusion: Our findings showed that prevalence of MS is lower in mineral areas and probably, 
living in these areas isn’t a predisposing factor for MS.
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INTRODUCTION
Multiple sclerosis (MS) is the most common 
inflammatory-demyelinating disease of the central 
nervous system and also, the most frequent cause of 
non-traumatic neurologic disability in young and middle-
age adults 1. Our knowledge about its pathogenesis 
is still incomplete and etiology remains unknown, 
but according to current data the disease develops in 
genetically susceptible individuals and may require 
additional environmental triggers 2. Probably, the immune 
process is a consequence of the connections between 
environment and susceptibility genes 3. Infective disease, 
dietary, habits (such as smoking), industrial exposure, 
and living in ecological hazard areas could be considered 
environmental factors 4,5. Early observations showed that 
the prevalence of MS is variable among geographic areas 
but we still don’t have any confirmed data about the 
nature of these pathologic factors in ecological hazard 
areas 6. One of the most geographic differences among 
areas of the world is mines existence. Also, available 
articles provide evidences of the effect of metals in 
MS pathogenesis 7-9. For example, iron 10, selenium 11, 
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copper 12, calcium 13, lead 3, aluminium 14 are only a 
small part of a big list of metals that have introduced 
in MS pathogenesis. Not only researches in the other 
countries but also some studies in Iran have confirmed 
an imbalance in serum and CSF level of trace elements 
in MS patients 12,15-17. According to our review in many 
medical resources including Pubmed, there isn’t any 
published epidemiologic study about prevalence of MS 
related to mines. Because Kerman province is a vest state 
with several important and different mines, we decided 
to do this research in this area. Our project is the first 
pilot study in this field and helps to identify the effect 
of environmental factors on MS pathogenesis.
PATIENTS AND METHODS
Our study was conducted in Kerman province. It covers 
an area of 181,714 km2 and includes 11% of the total area 
of the country. It is located in the south-eastern part of 
the country bounded by the provinces of Hormozgan in 
the south, Yazd and South Khorasan in the north, Fars 
in the west and the provinces of Sistan and Balochestan 
in the east. The main townships of Kerman province are; 
Baft, Bam, Jiroft, Rafsanjan, Zarand, Sirjan, Shahrbabak, 
Kahnoj and Kerman. The main mines in province of 
Kerman are iron, cooper, chrome and titanium. The 
province has a population of approximately 3 millions 
according to the national census in 2011 18.
Data collection
This cross-sectional study was conducted on 932 
patients in 2012. All of them were known cases of MS 
and resident in Kerman province. The disease data were 
collected from documents of MS centres of Kerman 
and Rafsanjan Universities of Medical Science 19. They 
were all diagnosed with MS by a neurologist and the 
MS committees (including at least 3 neurologists) in 
Kerman and Rafsanjan Universities of Medical Science 
had confirmed the diagnosis according to the revised 
Mc-Donald criteria 2010 20. The details of the patients 
including age, sex, age at the onset of disorder and disease 
duration were extracted from the records. The study was 
approved by the Neurology Research Centre of Kerman 
University of Medical Sciences.
Statistical analyses
Prevalence was defined as the total number of patients 
with a diagnosis of MS per 100,000 inhabitants. To analyze 
the data, SPSS-17 software and descriptive statistics (mean, 
frequency percent, and standard deviation) and t-test were 
used and p≤0.05 was considered statistically significant.
RESULTS
In the present study, 932 patients were evaluated. The 
male/female ratio was 1:3. The mean age of male and 
female were 38.1±9.72 and 36.12±9.97, respectively. 
Mean age at the onset of disease was 28.35 years (29±8.73 
for men and 28±8.3 for women) (P<0.05). Also, the mean 
duration of illness was 8.2±1 year (8.4±1.2 for men and 
8.7±0.5 for women) (P=0.30). The prevalence of MS in 
Kerman province was 31.7 per 100000. Kerman, Srjan, 
Zarand and Rafsanjan had the highest prevalence of 
MS respectively (Table 1). The mean prevalence of MS 
in mineral areas in Kerman province (Kahnoj, Sirjan, 
Zarand, Rafsanjan, Baft, Shahrbabak) was 23.01±10.78 
and in non-mineral areas (Kerman, Bam, Jiroft) was 
39.56±20.34 that show the higher prevalence of MS in 
non mineral areas of Kerman province. In addition, the 
highest prevalence of MS was seen in the areas that had 
chrome, iron and cooper mines, respectively (Table 2).
CONCLUSION
Our study evaluated the prevalence of MS according 
to mines in Kerman province. Our findings show that 
the prevalence of MS is higher in non mineral areas in 
comparison mineral areas. In addition, our study showed 
that the prevalence of MS in all kind of mines is lower than 
mean prevalence of MS in non-mineral areas (Table 1,2). 
We have not find any similar articles in literature review to 
compare our results with them It seems that our research 
is the first in this field. According our findings, we think 
that living in mineral areas is not a predisposing factor for 
Area Mine Prevalence
Kerman Non 57.3
Baft Chrome 31
Shahrbabak Cooper 13.1
Rafsanjan Cooper 27.1
Sirjan Iron 31.8
Zarand Iron 27.2
Bam Non 17.5
Jiroft Non 14.2
Kahnoj Titanium 1.9
Kerman province 31.7 
Table 1. Prevalence of MS in Kerman province and main townships.
Mine Township Prevalence
Iron Sirjan, Zarand 29.6
Cooper Rafsanjan, Shahrbabak 22.5
Chrome Baft 31
Titanium Kahnoj 1.9
Non Kerman, Bam, Jiroft 39.5
Table 2. Prevalence of MS according to mines in townships of 
Kerman province.
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MS genesis and we should search for other environmental 
factors in MS etiology. However, we are confronted with 
the following facts about trace elements. First, available 
literature provides evidences of abnormal level of trace 
elements in clinically definite MS and also clinically 
isolated syndrome 21-24. These studies are done on serum, 
cerebrospinal fluid, urine and hair 7,10,25-27 and including 
metals such as magnesium 28, iron 10, mercury 29, selenium 
11, copper 12,30, calcium 13, zinc, chrome, lead, titanium 
3,30, aluminum and many others 14. Second, in MS animal 
models, some metals (such as copper) have been seen to 
attenuate experimental autoimmune encephalomyelitis, 
this fact would suggest a role of metals in MS initiation 
and progression 31. Third, some studies showed a gradual 
accumulation of some metals (for example iron) in MS 
patients’ brain especially in oligodendrocytes 32,33. Since 
the main role of oligodendrocyte is myelin production 
and the myelin sheath of neurons are damaged in this 
disease, probably an imbalance of metals may lead to 
brain tissue inflammation and eventually to MS disease 
25,28,34. Forth, some metals (such as zinc, and mercury) 
are involved in autoimmunity response such as cytokine 
production, and we know that inflammation is a main 
picture of MS 29,35. Also, trace elements are crucial for 
the development of the nervous system, myelination of 
the nerve fibers, and neuronal excitability. The ability 
of metals to promote neuronal damage and neurological 
dysfunction has been linked to their role in catalyzing 
the formation of superoxide anion (O2.-), singlet oxygen 
(1O2) and hydrogen peroxide H2O2, which, in turn, are 
important mediators of oxidative reactions of biological 
macromolecules involved in neurodegenerative processes 
27-36. According to these facts (that show the effects of 
minerals on MS) and our finding (that show the low 
prevalence of MS in mineral areas) we hypothesize that 
the nature of these metal abnormalities is related to MS 
pathogenesis than environmental effect.
It should be noted that our study was a pilot 
epidemiologic study and the results should be evaluated 
with caution. Still it is unclear metal interactions are a 
primary or secondary factor, or a consequence of the 
neurodegeneration and further studies in this field are 
needed. Lack of evaluation of place of birth and migration 
were our study limitations and should be corrected in 
further studies. In conclusion, our findings showed that 
prevalence of MS is lower in mineral areas and probably, 
living in these areas isn’t a predisposing factor for MS.
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